Literature DB >> 29512295

Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings.

Sandra M Holley1, Talia Kamdjou1, Jack C Reidling2, Brian Fury3, Dane Coleal-Bergum3, Gerhard Bauer3, Leslie M Thompson2,4,5, Michael S Levine1, Carlos Cepeda1.   

Abstract

The principal symptoms of Huntington's disease (HD), chorea, cognitive deficits, and psychiatric symptoms are associated with the massive loss of striatal and cortical projection neurons. As current drug therapies only partially alleviate symptoms, finding alternative treatments has become peremptory. Cell replacement using stem cells is a rapidly expanding field that offers such an alternative. In this review, we examine recent studies that use mesenchymal cells, as well as pluripotent, cell-derived products in animal models of HD. Additionally, we provide further electrophysiological characterization of a human neural stem cell line, ESI-017, which has already demonstrated disease-modifying properties in two mouse models of HD. Overall, the field of regenerative medicine represents a viable and promising avenue for the treatment of neurodegenerative disorders including HD.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  Huntington's disease; animal models; electrophysiology; stem cells

Mesh:

Year:  2018        PMID: 29512295      PMCID: PMC6489814          DOI: 10.1111/cns.12839

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  125 in total

1.  Paucity of P-zones in striatal grafts prohibit commencement of clinical trials in Huntington's disease.

Authors:  P Brundin; R A Fricker; N Nakao
Journal:  Neuroscience       Date:  1996-04       Impact factor: 3.590

Review 2.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

Review 3.  Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings.

Authors:  Sandra M Holley; Talia Kamdjou; Jack C Reidling; Brian Fury; Dane Coleal-Bergum; Gerhard Bauer; Leslie M Thompson; Michael S Levine; Carlos Cepeda
Journal:  CNS Neurosci Ther       Date:  2018-03-06       Impact factor: 5.243

4.  Differential sensitivity of medium- and large-sized striatal neurons to NMDA but not kainate receptor activation in the rat.

Authors:  C Cepeda; J N Itri; J Flores-Hernández; R S Hurst; C R Calvert; M S Levine
Journal:  Eur J Neurosci       Date:  2001-11       Impact factor: 3.386

5.  Multilineage potential of adult human mesenchymal stem cells.

Authors:  M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

6.  D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.

Authors:  C R Gerfen; T M Engber; L C Mahan; Z Susel; T N Chase; F J Monsma; D R Sibley
Journal:  Science       Date:  1990-12-07       Impact factor: 47.728

Review 7.  Use of human stem cells in Huntington disease modeling and translational research.

Authors:  Monika M Golas; Bjoern Sander
Journal:  Exp Neurol       Date:  2016-01-27       Impact factor: 5.330

8.  Human glia can both induce and rescue aspects of disease phenotype in Huntington disease.

Authors:  Abdellatif Benraiss; Su Wang; Stephanie Herrlinger; Xiaojie Li; Devin Chandler-Militello; Joseph Mauceri; Hayley B Burm; Michael Toner; Mikhail Osipovitch; Qiwu Jim Xu; Fengfei Ding; Fushun Wang; Ning Kang; Jian Kang; Paul C Curtin; Daniela Brunner; Martha S Windrem; Ignacio Munoz-Sanjuan; Maiken Nedergaard; Steven A Goldman
Journal:  Nat Commun       Date:  2016-06-07       Impact factor: 14.919

9.  Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes.

Authors: 
Journal:  Cell Stem Cell       Date:  2012-06-28       Impact factor: 24.633

10.  Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models.

Authors:  Kari Pollock; Heather Dahlenburg; Haley Nelson; Kyle D Fink; Whitney Cary; Kyle Hendrix; Geralyn Annett; Audrey Torrest; Peter Deng; Joshua Gutierrez; Catherine Nacey; Karen Pepper; Stefanos Kalomoiris; Johnathon D Anderson; Jeannine McGee; William Gruenloh; Brian Fury; Gerhard Bauer; Alexandria Duffy; Theresa Tempkin; Vicki Wheelock; Jan A Nolta
Journal:  Mol Ther       Date:  2016-01-14       Impact factor: 11.454

View more
  8 in total

Review 1.  Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings.

Authors:  Sandra M Holley; Talia Kamdjou; Jack C Reidling; Brian Fury; Dane Coleal-Bergum; Gerhard Bauer; Leslie M Thompson; Michael S Levine; Carlos Cepeda
Journal:  CNS Neurosci Ther       Date:  2018-03-06       Impact factor: 5.243

2.  Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models.

Authors:  Carlos Cepeda; Michael S Levine
Journal:  Neuroscientist       Date:  2020-11-16       Impact factor: 7.235

Review 3.  Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders.

Authors:  Aurélie de Rus Jacquet; Hélèna L Denis; Francesca Cicchetti; Melanie Alpaugh
Journal:  Mol Psychiatry       Date:  2021-01-25       Impact factor: 13.437

4.  Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington's disease.

Authors:  Zheng Wu; Matthew Parry; Xiao-Yi Hou; Min-Hui Liu; Hui Wang; Rachel Cain; Zi-Fei Pei; Yu-Chen Chen; Zi-Yuan Guo; Sambangi Abhijeet; Gong Chen
Journal:  Nat Commun       Date:  2020-02-27       Impact factor: 14.919

Review 5.  Huntington's disease mouse models: unraveling the pathology caused by CAG repeat expansion.

Authors:  Julia Kaye; Terry Reisine; Steve Finkbeiner
Journal:  Fac Rev       Date:  2021-10-21

Review 6.  Synaptic pathology in Huntington's disease: Beyond the corticostriatal pathway.

Authors:  Joshua Barry; Minh T N Bui; Michael S Levine; Carlos Cepeda
Journal:  Neurobiol Dis       Date:  2021-11-27       Impact factor: 7.046

Review 7.  Pathogenesis and potential therapeutic application of stem cells transplantation in Huntington's disease.

Authors:  Sudeepto Saha; Manami Jayati Dey; Salman Khan Promon; Yusha Araf
Journal:  Regen Ther       Date:  2022-09-25       Impact factor: 3.651

Review 8.  Delaying memory decline: different options and emerging solutions.

Authors:  Felicitas Schneider; Alan Horowitz; Klaus-Peter Lesch; Thomas Dandekar
Journal:  Transl Psychiatry       Date:  2020-01-21       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.